ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 104 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,152 | -48.7% | 43,384 | -36.0% | 0.00% | – |
| Q2 2023 | $253,535 | +104235.4% | 67,790 | -6.7% | 0.00% | – |
| Q1 2023 | $243 | -71.9% | 72,658 | -59.6% | 0.00% | – |
| Q4 2022 | $864 | -100.0% | 179,686 | +55.3% | 0.00% | -100.0% |
| Q3 2021 | $4,055,000 | +102.5% | 115,671 | +256.8% | 0.00% | +100.0% |
| Q1 2021 | $2,002,000 | – | 32,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |